<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04662346</url>
  </required_header>
  <id_info>
    <org_study_id>Difficulty Score RPD</org_study_id>
    <nct_id>NCT04662346</nct_id>
  </id_info>
  <brief_title>Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy</brief_title>
  <official_title>Difficulty Scoring System in Robotic Pancreatoduodenectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pisa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pisa</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Robotic pancreatoduodenectomy is the most complex surgery for a general surgeon and&#xD;
      consequently a pancreatic surgeon can aspire to. Due to the close proximity of the pancreas&#xD;
      to the large vessels, great skill and experience in the field of pancreatic surgery, robotic&#xD;
      surgery and also vascular surgery is essential. The ability to predict the depth of robotic&#xD;
      pancreatoduodenectomy in each individual patient would be extremely important, for patient&#xD;
      selection and for the implementation of the learning curve. This study aims to provide a&#xD;
      difficulty score (DS) for robotic pancreatoduodenectomy to be used to select cases based on&#xD;
      the experience and expertise of the surgeon.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our Robot DIFFICULT Score was developed starting from factors evaluated by surgeons with&#xD;
      experience in performing robotic pancreatoduodenectomy in high-volume centers. Based on the&#xD;
      univariate and multivariate analysis, the elevated BMI, ASA 3, the need for venous resection&#xD;
      and vascular variations in arterial liver supply were considered significant in increasing&#xD;
      the degree of &quot;difficulty&quot; in the robotic pancreatoduodenectomy. The Robot ADDICT Score will&#xD;
      be calculated in all cases of the International Consortium on Minimally Invasive Pancreatic&#xD;
      Surgery (I-MIPS; www.i-mips.com).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>correlation to post-operative complication</measure>
    <time_frame>6 months</time_frame>
    <description>the score increase as complications increase</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Pancreatic Neoplasm</condition>
  <arm_group>
    <arm_group_label>patients undergoing robotic pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients have pancreatic neoplasm and undergoing robotic pancreatoduodenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Difficulty score system for robotic pancreatoduodenectomy</intervention_name>
    <description>calculate the score for patient in you cohort</description>
    <arm_group_label>patients undergoing robotic pancreatoduodenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  pathology of the head of pancreas requiring surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pathology of the head of pancreas not requiring surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ugo boggi</last_name>
    <role>Study Chair</role>
    <affiliation>University of Pisa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of pancreatic surgery</name>
      <address>
        <city>Pisa</city>
        <zip>56125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pisa</name>
      <address>
        <city>Pisa</city>
        <zip>56125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 30, 2020</study_first_submitted>
  <study_first_submitted_qc>December 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>December 5, 2020</last_update_submitted>
  <last_update_submitted_qc>December 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pisa</investigator_affiliation>
    <investigator_full_name>Concetta Cacace</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>creation of the formula, validation</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>6 month</ipd_time_frame>
    <ipd_access_criteria>surgeon</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

